{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:41:10Z","timestamp":1793166070825,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09784-4","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:03:25Z","timestamp":1751958205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Contemporary outcomes in no-option chronic limb-threatening ischemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Anahita","family":"Dua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Ferrer","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Bunte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Mart\u00ednez-Trabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Ghandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar S.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zola","family":"N\u2019Dandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi H.","family":"Shishehbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"9784_CR1","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jama.286.10.1195","volume":"286","author":"AH Mokdad","year":"2001","unstructured":"Mokdad, A. H. et al. The continuing epidemics of obesity and diabetes in the united States. JAMA 286, 1195\u20131200. https:\/\/doi.org\/10.1001\/jama.286.10.1195 (2001).","journal-title":"JAMA"},{"key":"9784_CR2","doi-asserted-by":"publisher","first-page":"e875","DOI":"10.1161\/CIR.0000000000000967","volume":"143","author":"MA Creager","year":"2021","unstructured":"Creager, M. A. et al. Reducing nontraumatic Lower-Extremity amputations by 20% by 2030: time to get to our feet: A policy statement from the American heart association. Circulation 143, e875\u2013e891. https:\/\/doi.org\/10.1161\/CIR.0000000000000967 (2021).","journal-title":"Circulation"},{"key":"9784_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jvs.2017.07.122","volume":"67","author":"J Okazaki","year":"2018","unstructured":"Okazaki, J. et al. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia. J. Vasc Surg. 67, 817\u2013825. https:\/\/doi.org\/10.1016\/j.jvs.2017.07.122 (2018).","journal-title":"J. Vasc Surg."},{"key":"9784_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","volume":"51","author":"B Sigvant","year":"2016","unstructured":"Sigvant, B., Lundin, F. & Wahlberg, E. The risk of disease progression in peripheral arterial disease is higher than expected: A Meta-Analysis of mortality and disease progression in peripheral arterial disease. Eur. J. Vasc Endovasc Surg. 51, 395\u2013403. https:\/\/doi.org\/10.1016\/j.ejvs.2015.10.022 (2016).","journal-title":"Eur. J. Vasc Endovasc Surg."},{"key":"9784_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/VHRM.S209241","volume":"15","author":"S Duff","year":"2019","unstructured":"Duff, S., Mafilios, M. S., Bhounsule, P. & Hasegawa, J. T. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag. 15, 187\u2013208. https:\/\/doi.org\/10.2147\/VHRM.S209241 (2019).","journal-title":"Vasc Health Risk Manag"},{"key":"9784_CR6","first-page":"2694","volume":"1","author":"MI Ghare","year":"2021","unstructured":"Ghare, M. I. et al. Outcomes among patients with chronic critical limb ischemia with no revascularization option: systematic review and Meta-Analysis. J. Crit. Limb Ischemia. 1, 2694 (2021).","journal-title":"J. Crit. Limb Ischemia"},{"key":"9784_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1089\/pop.2015.0181","volume":"20","author":"WR Rowley","year":"2017","unstructured":"Rowley, W. R. et al. : Insights from Yesterday, Today, and Future Trends. Popul Health Manag 20, 6\u201312. https:\/\/doi.org\/10.1089\/pop.2015.0181 (2017).","journal-title":"Popul Health Manag"},{"key":"9784_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren, L. et al. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J. Vasc Surg. 45, 5\u201367. https:\/\/doi.org\/10.1016\/j.jvs.2006.12.037 (2007).","journal-title":"J. Vasc Surg."},{"key":"9784_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ahj.2012.12.002","volume":"165","author":"WS Jones","year":"2013","unstructured":"Jones, W. S. et al. High mortality risks after major lower extremity amputation in medicare patients with peripheral artery disease. Am. Heart J. 165, 809\u2013815. https:\/\/doi.org\/10.1016\/j.ahj.2012.12.002 (2013).","journal-title":"Am. Heart J."},{"key":"9784_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jvs.2012.11.068","volume":"57","author":"PP Goodney","year":"2013","unstructured":"Goodney, P. P. et al. Regional intensity of vascular care and lower extremity amputation rates. J. Vasc Surg. 57, 1471\u20131480. https:\/\/doi.org\/10.1016\/j.jvs.2012.11.068 (2013).","journal-title":"J. Vasc Surg."},{"key":"9784_CR11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1056\/NEJMoa2212754","volume":"388","author":"MH Shishehbor","year":"2023","unstructured":"Shishehbor, M. H. et al. Transcatheter arterialization of deep veins in chronic Limb-Threatening ischemia. N Engl. J. Med. 388, 1171\u20131180. https:\/\/doi.org\/10.1056\/NEJMoa2212754 (2023).","journal-title":"N Engl. J. Med."},{"key":"9784_CR12","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","volume":"69","author":"MS Conte","year":"2019","unstructured":"Conte, M. S. et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 69, 3\u2013125 e140. https:\/\/doi.org\/10.1016\/j.jvs.2019.02.016 (2019).","journal-title":"N Engl. J. Med."},{"key":"9784_CR13","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"AW Bradbury","year":"2023","unstructured":"Bradbury, A. W. et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet 401, 1798\u20131809. https:\/\/doi.org\/10.1016\/S0140-6736(23)00462-2 (2023).","journal-title":"Lancet"},{"key":"9784_CR14","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","volume":"387","author":"A Farber","year":"2022","unstructured":"Farber, A. et al. Surgery or endovascular therapy for chronic Limb-Threatening ischemia. N Engl. J. Med. 387, 2305\u20132316. https:\/\/doi.org\/10.1056\/NEJMoa2207899 (2022).","journal-title":"N Engl. J. Med."},{"key":"9784_CR15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jvs.2022.10.043","volume":"77","author":"EA Jaramillo","year":"2023","unstructured":"Jaramillo, E. A. et al. Racial and ethnic disparities in major adverse limb events persist for chronic limb threatening ischemia despite presenting limb threat severity after peripheral vascular intervention. J. Vasc Surg. 77, 848\u2013857. https:\/\/doi.org\/10.1016\/j.jvs.2022.10.043 (2023).","journal-title":"J. Vasc Surg."},{"key":"9784_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jvs.2022.06.026","volume":"76","author":"AC Anjorin","year":"2022","unstructured":"Anjorin, A. C. et al. Racial and ethnic disparities in 3-year outcomes following infrainguinal bypass for chronic limb-threatening ischemia. J. Vasc Surg. 76, 1335\u20131346. https:\/\/doi.org\/10.1016\/j.jvs.2022.06.026 (2022).","journal-title":"J. Vasc Surg."},{"key":"9784_CR17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","volume":"40","author":"JA Barnes","year":"2020","unstructured":"Barnes, J. A., Eid, M. A., Creager, M. A. & Goodney, P. P. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler. Thromb. Vasc Biol. 40, 1808\u20131817. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314595 (2020).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"9784_CR18","doi-asserted-by":"publisher","first-page":"e012798","DOI":"10.1161\/CIRCINTERVENTIONS.122.012798","volume":"17","author":"EA Secemsky","year":"2024","unstructured":"Secemsky, E. A. et al. Impact of intensity of vascular care preceding major amputation among patients with chronic Limb-Threatening ischemia. Circ. Cardiovasc. Interv. 17, e012798. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.122.012798 (2024).","journal-title":"Circ. Cardiovasc. Interv"},{"key":"9784_CR19","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1056\/NEJMp2215609","volume":"388","author":"AL Schwartz","year":"2023","unstructured":"Schwartz, A. L., Alsan, M., Morris, A. A. & Halpern, S. D. Why diverse clinical trial participation matters. N Engl. J. Med. 388, 1252\u20131254. https:\/\/doi.org\/10.1056\/NEJMp2215609 (2023).","journal-title":"N Engl. J. Med."},{"key":"9784_CR20","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamasurg.2016.2018","volume":"151","author":"A Farber","year":"2016","unstructured":"Farber, A. & Eberhardt, R. T. The current state of critical limb ischemia: A systematic review. JAMA Surg. 151, 1070\u20131077. https:\/\/doi.org\/10.1001\/jamasurg.2016.2018 (2016).","journal-title":"JAMA Surg."},{"key":"9784_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1526602818820792","volume":"26","author":"R Ferraresi","year":"2019","unstructured":"Ferraresi, R. et al. Hybrid foot vein arterialization in No-Option patients with critical limb ischemia: A preliminary report. J. Endovasc Ther. 26, 7\u201317. https:\/\/doi.org\/10.1177\/1526602818820792 (2019).","journal-title":"J. Endovasc Ther."},{"key":"9784_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.23736\/S0021-9509.18.10569-6","volume":"59","author":"S Kum","year":"2018","unstructured":"Kum, S. et al. Percutaneous deep venous arterialization in patients with critical limb ischemia. J. Cardiovasc. Surg. (Torino). 59, 665\u2013669. https:\/\/doi.org\/10.23736\/S0021-9509.18.10569-6 (2018).","journal-title":"J. Cardiovasc. Surg. (Torino)"},{"key":"9784_CR23","doi-asserted-by":"publisher","first-page":"100437","DOI":"10.1016\/j.jscai.2022.100437","volume":"1","author":"FA Saab","year":"2022","unstructured":"Saab, F. A. et al. Percutaneous deep venous arterialization: treatment of patients with End-Stage plantar disease. J. Soc. Cardiovasc. Angiography Interventions. 1, 100437. https:\/\/doi.org\/10.1016\/j.jscai.2022.100437 (2022).","journal-title":"J. Soc. Cardiovasc. Angiography Interventions"},{"key":"9784_CR24","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.jvscit.2023.101160","volume":"9","author":"M Montero-Baker","year":"2023","unstructured":"Montero-Baker, M., Sommerset, J. & Miranda, J. A. Hybrid superficial venous arterialization and endovascular deep venous arterialization. J. Vasc Surg. Cases Innov. Tech. 9, 101160. https:\/\/doi.org\/10.1016\/j.jvscit.2023.101160 (2023).","journal-title":"J. Vasc Surg. Cases Innov. Tech."},{"key":"9784_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2024.05.051","author":"N Saini","year":"2024","unstructured":"Saini, N., Marrone, L., Desai, S., Herman, K. C. & Rundback, J. H. Comparison of outcomes of percutaneous deep venous arterialization in multiple practice settings. J. Vasc Surg. https:\/\/doi.org\/10.1016\/j.jvs.2024.05.051 (2024).","journal-title":"J. Vasc Surg."},{"key":"9784_CR26","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.jvs.2021.04.057","volume":"74","author":"DG Clair","year":"2021","unstructured":"Clair, D. G. et al. PROMISE I: early feasibility study of the limflow system for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results. J. Vasc Surg. 74, 1626\u20131635. https:\/\/doi.org\/10.1016\/j.jvs.2021.04.057 (2021).","journal-title":"J. Vasc Surg."},{"key":"9784_CR27","doi-asserted-by":"publisher","first-page":"znae188","DOI":"10.1093\/bjs\/znae188","volume":"111","author":"H Zayed","year":"2024","unstructured":"Zayed, H. et al. Transcatheter arterialization of the deep veins: 1-year outcomes of PROMISE-UK study. Br. J. Surg. 111, znae188. https:\/\/doi.org\/10.1093\/bjs\/znae188 (2024).","journal-title":"Br. J. Surg."},{"key":"9784_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.avsg.2023.08.010","volume":"99","author":"RJ Powell","year":"2024","unstructured":"Powell, R. J., Mullin, C. M., Clair, D. G., Shishehbor, M. H. & Dua, A. Comparison of transcatheter arterialization of deep veins to standard of care in patients with No-Option chronic limb threatening ischemia. Ann. Vasc Surg. 99, 50\u201357. https:\/\/doi.org\/10.1016\/j.avsg.2023.08.010 (2024).","journal-title":"Ann. Vasc Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09784-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09784-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09784-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:03:26Z","timestamp":1751958206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09784-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9784"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09784-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AD: Educational consultant for Boston Scientific, Abbott, Penumbra, Gore. RJP: No disclosures. ACL: Advisory Board for FastWave Medical, Consultant for Abbott, BD, Cook Medical, Inari Medical. NB: No disclosures. JLM: Advisory Board for Xylocor and IsomAb. LFC: No disclosures. MCB: Consultant for Abbott Vascular, Shockwave Medical, Amgen, and Inari Medical; Institutional research support from Inari Medical and Johnson and Johnson. JLMT: No disclosures. SG: No disclosures. SSG: No disclosures. ZND: No disclosures. PAS has nothing to disclose. DC: Advisory and consultant for Boston Scientific, Bard Peripheral Vascular, Medtronic, and LimFlow. MHS: Advisory and consultant for Abbott Vascular, Medtronic, Terumo, Boston Scientific, Philips, ANT, Inquis Medical, and Inari Medical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24446"}}